Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Conference

Event
-
April 9, 2025

genOway's presentation on Wednesday, 9 April, 2025 | 2:15 p.m. CEST:

‍

Assessment of translational tumor biology and efficacy in humanized mouse models:‍

  • Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
  • Investigating human immune cell recruitment into tumor microenvironment
  • Examining the functionality of myeloid cells and their contribution to translatable safety assessment of therapies
  • Showcasing a mouse model expressing human Fc receptors as tools for translational assessment of Fc receptor-targeted therapies

Tumour Models Nordics, Stockholm, Sweden, April 9-10, 2025

Get in touch

Let us know how we can help

Other news & events

The 55th Annual Meeting of the Japanese Society for Immunology, Osaka, November 17-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
18th annual PEGS Europe, Lisbon, Portugal, November 16-19, 2026
Conference
genOway presentation
Event
-
Nov 2026
Read on
The 41st Annual Meeting of the Japanese Society for the Study of Xenobiotics in Tukuba, Japan, November 16-19, 2026
Conference
Event
-
Nov 2026
Read on
SITC meeting 2026, Phoenix, Arizona, November 4-8
Conference
genOway presentation
Event
-
Nov 2026
Read on
2nd T-Cell Engager for Autoimmune Disease Summit, Boston, October 27-29, 2026
Conference
genOway presentation
Event
-
Oct 2026
Read on
Scientific excellence

From model design to experimental results
Featured in 600+ scientific articles

Collaborative approach

Collaboration with 17 Top Pharmas,
170+ Biotechs and 380+ Academic Institutions

Robust validation data on catalog models

Generated with biopharma partners and in-house

Innovative technologies

and guaranteed freedom to operate

Easy access to models

Models with certified health status from professional breeders in US and Europe